Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Sale of Shares to Cover Taxes

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the sale of 5,479 shares of Class A Common Stock to cover taxes upon vesting of restricted stock units.

Summary

• On March 24, 2025, Mark Leonard Singleton, SVP & CFO of Bioventus Inc., sold 5,479 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $9.79 per share.
• The transaction was made pursuant to a standing 10b5-1 instruction adopted on April 4, 2022, to cover taxes upon the vesting of restricted stock units on March 21, 2025.
• Following the transaction, Singleton directly owns 131,963 shares of Bioventus Inc. Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, executed under a pre-existing 10b5-1 plan. It doesn't necessarily reflect a positive or negative view of the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's valuation and future prospects. Sales to cover tax obligations are common and don't necessarily indicate a negative outlook.

Stakeholder Impact

• The sale of shares by an insider could be perceived neutrally by shareholders, as it is related to tax obligations and executed under a pre-existing plan.

Key Dates

Keywords

Form 4, Bioventus Inc., BVS, Mark Leonard Singleton, SVP & CFO, Stock Sale, 10b5-1 Plan, Insider Trading